Seagen to Report First Quarter 2023 Financial Results on April 27, 2023

Rhea-AI Summary

Seagen Inc. (NASDAQ: SGEN) announced it will report its first quarter 2023 financial results on April 27, 2023. In light of its recent acquisition agreement with Pfizer, the company will forgo hosting a conference call for this quarter's results. Seagen is a biotech firm focused on developing transformative cancer treatments. The company is headquartered in the Seattle area and has additional locations in California, Canada, Switzerland, and the European Union.

BOTHELL, Wash.--(BUSINESS WIRE)-- Seagen Inc. (Nasdaq: SGEN) today announced that it will report its first quarter 2023 financial results on Thursday, April 27, 2023.

Given the recently announced agreement to be acquired by Pfizer Inc., Seagen will not be hosting a conference call.

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230407005028/en/

For Investors

Douglas Maffei, Ph.D.

Vice President, Investor Relations

(425) 527-4881

dmaffei@seagen.com

For Media

David Caouette

Vice President, Corporate Communications

(310) 430-3476

dcaouette@seagen.com

Source: Seagen Inc.

FAQ

When will Seagen report its Q1 2023 financial results?

Seagen will report its first quarter 2023 financial results on April 27, 2023.

Will Seagen host a conference call for Q1 2023 results?

No, Seagen will not be hosting a conference call due to its acquisition agreement with Pfizer.

What is the acquisition agreement involving Seagen?

Seagen has recently announced an agreement to be acquired by Pfizer.